Expression of focal adhesion kinase in normal and pathologic human prostate tissues.
about
FYN is overexpressed in human prostate cancerThe chemopreventive retinoid 4HPR impairs prostate cancer cell migration and invasion by interfering with FAK/AKT/GSK3beta pathway and beta-catenin stabilityDifferential requirement for focal adhesion kinase signaling in cancer progression in the transgenic adenocarcinoma of mouse prostate modelMitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment.Paxillin-Y118 phosphorylation contributes to the control of Src-induced anchorage-independent growth by FAK and adhesion.Cellular responses to substrate topography: role of myosin II and focal adhesion kinase.Increased expression of focal adhesion kinase in thyroid cancer: immunohistochemical study.Therapeutic value of quinazoline-based compounds in prostate cancer.Focal adhesion kinase, a downstream mediator of Raf-1 signaling, suppresses cellular adhesion, migration, and neuroendocrine markers in BON carcinoid cellsSrc family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530.Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells.Molecular pathways triggering glioma cell invasion.Therapeutic effects of tyroservatide on metastasis of lung cancer and its mechanism affecting integrin-focal adhesion kinase signal transduction.Nonreceptor tyrosine kinases in prostate cancer.Expression of focal adhesion kinase in small-cell lung carcinoma.Focal adhesion kinase as an immunotherapeutic target.Progesterone enhances vascular endothelial cell migration via activation of focal adhesion kinase.β1 integrin- and JNK-dependent tumor growth upon hypofractionated radiation.Integrin signaling aberrations in prostate cancer.Steps in prostate cancer progression that lead to bone metastasisActivity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets.Down regulation of RhoC by microRNA-138 results in de-activation of FAK, Src and Erk1/2 signaling pathway in head and neck squamous cell carcinoma.Effects of lysophosphatidic acid on calpain-mediated proteolysis of focal adhesion kinase in human prostate cancer cells.Dual focal adhesion kinase/Pyk2 inhibitor has positive effects on bone tumors: implications for bone metastases.Human cytomegalovirus infection alters PC3 prostate carcinoma cell adhesion to endothelial cells and extracellular matrix.Expression of pY397 FAK promotes the development of non-small cell lung cancer.Expression of GRP and its receptor in well-differentiated colon cancer cells correlates with the presence of focal adhesion kinase phosphorylated at tyrosines 397 and 407.Focal adhesion kinase overexpression: correlation with lymph node metastasis and shorter survival in oral squamous cell carcinoma.Association of the upregulated expression of focal adhesion kinase with poor prognosis and tumor dissemination in hypopharyngeal cancer.In oral squamous cell carcinoma, high FAK expression is correlated with low P53 expression.
P2860
Q28300097-B168D996-C56A-4DDB-9223-204C16DFC7B2Q28396729-DD30B8DC-F15D-446E-9EF8-DB6080C2D7D2Q30435351-CC666C66-5558-4BF1-84A7-A1C83F1B579DQ30437556-29B9C8E3-6AE7-4B5B-828B-D84891206CE0Q30440086-971CB422-522F-4EFA-A888-307CACD26AAFQ30477152-0C73149A-FACB-4964-ADBA-E6DD9A20A642Q33629720-DEF326EC-91F0-4FE7-B474-C7163794B181Q33746225-D9937169-9670-47D3-BEC7-805C22DBB3FCQ33861019-2334E209-2A7F-4CB3-A1B1-51A8F117D0F1Q34959208-ED2C8616-4CBE-42D1-AB8A-35948EA847ACQ35832949-71A9A087-CDEB-4820-BA5E-A0F096938944Q36528894-7B2AF66F-0BDE-48A1-A790-DD15480A33C3Q36659321-4D4802E2-861A-4541-8C53-CEFCBA125C84Q36759212-BE74C43E-05A2-4045-86EE-010FB5BD1E3AQ36905888-EDA28B4E-4D14-4ABF-A869-DC82A96D0B26Q37147823-57E0F357-69FE-445A-A7E8-E2589D038E29Q37295760-097DE1F2-DC00-41C8-9BBC-C3B71CC9E22DQ37619636-78C9FF38-E286-44DB-8C47-42DA94B14C8EQ37643449-1224BE16-FA80-42C4-9370-D4A2FB41CAAFQ37848782-F13C8E35-D43F-4112-90B8-4C875B17F4CFQ38763251-DD170B73-43CF-4983-A056-E00BE3CCB174Q39021212-F8244762-8047-4C2D-8C72-9A1EBDF82D82Q39369727-8025686F-36B2-43E0-9FE8-1B65757BC441Q40001204-6FAE1362-0B12-4550-B924-9956DC12F5FEQ40221683-D8618085-C219-42D9-9278-900D5FEB5E8FQ42538360-D6A04C37-36E8-417F-99B6-131D1BD9DC23Q44519414-28F7BD26-E58D-4F07-8355-4C783D39D343Q45351701-CEF1F5AF-68B6-4F7C-918C-6BEFD1391A67Q53126273-297210D5-857D-4285-B5D7-282899A8327CQ54497749-A968B39A-101B-49FC-889F-E69AEB73EA82
P2860
Expression of focal adhesion kinase in normal and pathologic human prostate tissues.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Expression of focal adhesion kinase in normal and pathologic human prostate tissues.
@ast
Expression of focal adhesion kinase in normal and pathologic human prostate tissues.
@en
type
label
Expression of focal adhesion kinase in normal and pathologic human prostate tissues.
@ast
Expression of focal adhesion kinase in normal and pathologic human prostate tissues.
@en
prefLabel
Expression of focal adhesion kinase in normal and pathologic human prostate tissues.
@ast
Expression of focal adhesion kinase in normal and pathologic human prostate tissues.
@en
P2093
P2860
P356
P1433
P1476
Expression of focal adhesion kinase in normal and pathologic human prostate tissues.
@en
P2093
Henry F Frierson
J Thomas Parsons
Joshua D Rovin
Reid B Adams
Wayne Ledinh
P2860
P304
P356
10.1002/PROS.10114
P577
2002-10-01T00:00:00Z